Last updated: 24 July 2019 at 2:27pm EST

Jurgen Drews Net Worth




The estimated Net Worth of Jurgen Drews is at least $252 Milion dollars as of 28 May 2004. Jurgen Drews owns over 70,000 units of PDL Biopharma Inc stock worth over $252,420,000 and over the last 21 years Jurgen sold PDLI stock worth over $0.

Jurgen Drews PDLI stock SEC Form 4 insiders trading

Jurgen has made over 2 trades of the PDL Biopharma Inc stock since 2004, according to the Form 4 filled with the SEC. Most recently Jurgen exercised 70,000 units of PDLI stock worth $678,300 on 28 May 2004.

The largest trade Jurgen's ever made was exercising 70,000 units of PDL Biopharma Inc stock on 28 May 2004 worth over $678,300. On average, Jurgen trades about 39,333 units every 0 days since 2003. As of 28 May 2004 Jurgen still owns at least 70,000 units of PDL Biopharma Inc stock.

You can see the complete history of Jurgen Drews stock trades at the bottom of the page.



What's Jurgen Drews's mailing address?

Jurgen's mailing address filed with the SEC is C/O PROTEIN DESIGN LABS, INC., 34801 CAMPUS DRIVE, FREMONT, CA, 94555.

Insiders trading at PDL Biopharma Inc

Over the last 22 years, insiders at PDL Biopharma Inc have traded over $45,966,964 worth of PDL Biopharma Inc stock and bought 12,693,393 units worth $32,804,545 . The most active insiders traders include Point Capital L.P.O'shea Ro..., Faheem Hasnain a Laurence Jay Korn. On average, PDL Biopharma Inc executives and independent directors trade stock every 24 days with the average trade being worth of $245,074,578. The most recent stock trade was executed by Point Capital L.P.O'shea Ro... on 1 February 2021, trading 187,061 units of PDLI stock currently worth $383,475.



What does PDL Biopharma Inc do?



Complete history of Jurgen Drews stock trades at PDL Biopharma Inc

Osoba
Trans.
Transakce
Celková cena
Jurgen Drews
Ředitel
Využití opce $678,300
28 May 2004
Jurgen Drews
Ředitel
Využití opce $318,720
27 May 2004


PDL Biopharma Inc executives and stock owners

PDL Biopharma Inc executives and other stock owners filed with the SEC include: